First targeted therapy for multiple myeloma effective against hard-to-treat disease

Share :
Published: 6 Dec 2015
Views: 2182
Rating:
Save
Dr Torben Plesner - Vejle Hospital, University of Southern Denmark, Vejle, Denmark

Dr Plesner presents, at a press conference at ASH 2015, updated results of a phase I/II study (GEN503) looking at daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma. 

Read the news story and watch the video interview for more information.